New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

The rapid test newcomer offers fast, reliable respiratory diagnostics — a timely addition to the American healthcare toolkit.

By targeting a previously unexploited metabolic pathway essential for bacterial survival, the drug candidate may offer the ...

Scratching an itchy rash really does make it worse, according to new research. But it can also provide defence against bacterial skin infections, say American scientists. New research, published in ...

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...

Lumos Diagnostics signs exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of FebriDX in US.

Lumos Diagnostics shares today soared by more than 150pc after the company unveiled a US distribution deal worth as much as ...

Lumos Diagnostics (ASX:LDX) has surged +140% to sell at 7cps in Wednesday’s lunchtime trade after inking a $420 million deal ...

A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and ...

In the ongoing battle against antibiotic-resistant bacteria, MSU researchers have made a discovery that could reshape how we ...

BiomX has dosed the first subject in the randomised Phase IIb trial of the company’s fixed multi-phage therapy, BX004, to ...